REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 105 filers reported holding REVANCE THERAPEUTICS INC in Q4 2015. The put-call ratio across all filers is 0.89 and the average weighting 1.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $1,629,000 | +27.3% | 78,719 | -0.3% | 0.00% | 0.0% |
| Q3 2016 | $1,280,000 | +20.2% | 78,950 | +0.8% | 0.00% | +100.0% |
| Q2 2016 | $1,065,000 | -6.4% | 78,313 | +20.2% | 0.00% | 0.0% |
| Q1 2016 | $1,138,000 | -47.8% | 65,170 | +2.2% | 0.00% | -66.7% |
| Q4 2015 | $2,179,000 | +32.5% | 63,776 | +15.3% | 0.00% | +50.0% |
| Q3 2015 | $1,645,000 | -7.6% | 55,292 | -0.7% | 0.00% | 0.0% |
| Q2 2015 | $1,780,000 | +219.0% | 55,668 | +106.6% | 0.00% | +100.0% |
| Q1 2015 | $558,000 | +24.0% | 26,941 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $450,000 | -11.6% | 26,536 | +0.8% | 0.00% | 0.0% |
| Q3 2014 | $509,000 | -30.3% | 26,314 | +22.5% | 0.00% | 0.0% |
| Q2 2014 | $730,000 | +20.7% | 21,483 | +11.9% | 0.00% | 0.0% |
| Q1 2014 | $605,000 | – | 19,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Palo Alto Investors LP | 4,405,039 | $118,936,000 | 9.40% |
| Essex Woodlands Management, Inc. | 457,085 | $12,341,000 | 5.10% |
| Evolutionary Tree Capital Management, LLC | 191,868 | $5,180,000 | 4.98% |
| Ghost Tree Capital, LLC | 390,000 | $10,530,000 | 2.96% |
| Antara Capital LP | 4,069,400 | $109,874,000 | 2.90% |
| RICE HALL JAMES & ASSOCIATES, LLC | 896,754 | $24,212,000 | 1.40% |
| Jericho Capital Asset Management L.P. | 714,000 | $19,278,000 | 1.22% |
| Antara Capital LP | 1,600,000 | $43,200,000 | 1.14% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 120,000 | $3,240,000 | 1.04% |
| TANG CAPITAL MANAGEMENT LLC | 287,500 | $7,763,000 | 0.95% |